Literature DB >> 16447235

PUMA regulation and proapoptotic effects in fibroblast-like synoviocytes.

Hoon-Suk Cha1, Sanna Rosengren, David L Boyle, Gary S Firestein.   

Abstract

OBJECTIVE: Although p53 is overexpressed in rheumatoid arthritis (RA) synovial tissue (ST), few synoviocytes undergo apoptosis. This could be partly due to low expression of proapoptotic genes. Deficient p53 up-regulated modulator of apoptosis (PUMA), which is a major effector of p53-mediated cell death, could contribute to this phenomenon. To evaluate a method to induce apoptosis, the expression and function of PUMA was investigated in ST and cultured fibroblast-like synoviocytes (FLS).
METHODS: PUMA expression in ST was measured by immunohistochemistry, Western blot analysis, and quantitative polymerase chain reaction analysis. Ad-p53 and plasmids encoding hemagglutinin-tagged, full-length PUMA expression vector (HA-PUMA), PUMA lacking the Bcl-2 homology 3 domain, or pCEP4 were used to transfect FLS. Apoptosis was quantified by trypan blue exclusion, DNA fragmentation, and caspase 3 activation.
RESULTS: PUMA protein was detected in RA ST, although most of the immunoreactive protein was localized to sublining cells rather than the intimal lining synoviocytes. Western blot analysis showed no difference between RA ST and osteoarthritis (OA) ST. PUMA messenger RNA was detected in RA and OA ST, although the amounts were markedly lower than in the spleen and FLS. To determine if PUMA was inducible, FLS were transduced with Ad-p53. Even though p53 protein was produced and p21 expression was increased, PUMA expression was not enhanced. Consistent with this observation, Ad-p53 did not induce apoptosis in FLS. However, HA-PUMA transfection into FLS resulted in rapid apoptosis with the activation of caspase 3.
CONCLUSION: PUMA can induce apoptosis by FLS and represents a potential target in RA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16447235     DOI: 10.1002/art.21631

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  29 in total

Review 1.  Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors.

Authors:  Nunzio Bottini; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

2.  Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis.

Authors:  John C Scatizzi; Jack Hutcheson; Richard M Pope; Gary S Firestein; Alisa E Koch; Melissa Mavers; Avraham Smason; Hemant Agrawal; G Kenneth Haines; Navdeep S Chandel; Richard S Hotchkiss; Harris Perlman
Journal:  Arthritis Rheum       Date:  2010-02

Review 3.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

4.  PUMA decreases the growth of prostate cancer PC-3 cells independent of p53.

Authors:  Zhengfei Shan; Qingzuo Liu; Yuling Li; Jitao Wu; Dekang Sun; Zhenli Gao
Journal:  Oncol Lett       Date:  2017-01-27       Impact factor: 2.967

5.  Aryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes.

Authors:  Tejas S Lahoti; Kaarthik John; Jarod M Hughes; Ann Kusnadi; Iain A Murray; Gowdahalli Krishnegowda; Shantu Amin; Gary H Perdew
Journal:  Ann Rheum Dis       Date:  2013-01-24       Impact factor: 19.103

Review 6.  BH3-only proteins in rheumatoid arthritis: potential targets for therapeutic intervention.

Authors:  J Hutcheson; H Perlman
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

Review 7.  The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases.

Authors:  Carla M Cuda; Richard M Pope; Harris Perlman
Journal:  Nat Rev Rheumatol       Date:  2016-08-23       Impact factor: 20.543

Review 8.  Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes.

Authors:  Gyrid Nygaard; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2020-05-11       Impact factor: 20.543

9.  SUMO-conjugating enzyme UBC9 promotes proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Faxin Li; Xueyan Li; Liqing Kou; Yi Li; Fanhua Meng; Fang Ma
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

10.  Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Authors:  Tejas S Lahoti; Jarod M Hughes; Ann Kusnadi; Kaarthik John; Bokai Zhu; Iain A Murray; Krishne Gowda; Jeffrey M Peters; Shantu G Amin; Gary H Perdew
Journal:  J Pharmacol Exp Ther       Date:  2013-12-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.